𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Requirement of e6ap and the features of human papillomavirus e6 necessary to support degradation of p53

✍ Scribed by Brooke Cooper; Steven Schneider; Joanna Bohl; Yong-hui Jiang; Arthur Beaudet; Scott Vande Pol


Book ID
114092951
Publisher
Elsevier Science
Year
2003
Tongue
English
Weight
607 KB
Volume
306
Category
Article
ISSN
0042-6822

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Dispensability of p53 degradation for tu
✍ Tadao Inoue; Kiyomasa Oka; Hwang Yong-II; Karen H. Vousden; Satoru Kyo; Pan Jing πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 202 KB

Certain types of human papillomavirus (HPV), such as types 16 and 18, are etiological agents for carcinogenesis of the uterine cervix. These HPVs have two oncogenes, E6 and E7, that have transforming activities in established murine cells. Tumorigenicity and decreased serum requirement for cell grow

Interference of proteins involved in the
✍ Jennifer S. Isaacs; J. Carl Barrett; Bernard E. Weissman πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 2 views

The oncogenic human papillomaviruses (HPVs) are able to efficiently target p53 for degradation by the ubiquitin pathway. We previously demonstrated inefficient HPV E6-mediated degradation and resulting high steady-state levels of p53 in cell hybrids between a peripheral neuroepithelioma cell line an

Targetting of the N-terminal domain of t
✍ Christine Giovane; Gilles TravΓ©; AmΓ©lie Briones; Yves Lutz; Bohdan Wasylyk; Etie πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 443 KB πŸ‘ 1 views

The E6 protein of cancer-associated human papillomavirus type 16 (HPV16) binds to cellular p53 and promotes its degradation through the ubiquitin pathway. In an attempt to identify the regions of E6 that could be targetted for functional inhibition, we generated monoclonal antibodies to the HPV16 E6